Figure 2
Probability curves of patients who were MRD negative or positive by flow cytometry or deep sequencing. (A) Relapse risk by pre-HCT NGS-MRD compared with MFC-MRD status. (B) OS by pre-HCT NGS-MRD compared with NGS-MRD status.
Probability curves of patients who were MRD negative or positive by flow cytometry or deep sequencing. (A) Relapse risk by pre-HCT NGS-MRD compared with MFC-MRD status. (B) OS by pre-HCT NGS-MRD compared with NGS-MRD status.
